A multiinstitutional study of 307 heart transplant recipients was carried out to determine the clinical, radiographic, and prognostic characteristics, the incidence, and the etiology of pneumonias in the first year after transplantation. There were 21.1 cases of pneumonia per 100 heart transplantations. Seventy-five percent of the cases occurred in the first trimester. Eighty-two causal agents were identified, of which 60% were opportunistic, 25% were nosocomial, and 15% were community-acquired. The most frequent isolates were cytomegalovirus (20), Aspergillus species (13), and Pneumocystis carinii (11). Hemoptysis occurred more frequently in aspergillus pneumonias than in other pneumonias (54% vs. 6%, respectively; P õ .05); aspergillus pneumonia was the only type of pneumonia during which cavitated nodules were noted on thoracic radiographs. The overall mortality rate was 30.8%; the independent factors of a poor prognosis were aspergillus infection (relative risk [RR], 7.4; 95% confidence interval [CI], 5.8 -9.1) and bilateral pulmonary infiltrates (RR, 10; 95% CI, 8.5 -11.4).
Heart transplantation (HT) has become a therapeutic reality traindications for the transplant. At all participating centers, donors and recipients underwent tuberculosis tests and serology in terminal cases of heart failure. In 1994, the rate of HTs in Spain was 7.6 per one million inhabitants, the third highest rate for CMV and Toxoplasma gondii. Preoperative prophylaxis with antimicrobials was also adworldwide [1] . Pneumonias are the most severe and common infectious complications afflicting heart transplant recipients.
ministered. The maintenance immunosuppressive treatment was the same in all centers, and the induction immunosuppresMany studies of these pneumonias have been carried out, espesive treatment was similar, only varying in the type of antilymcially those of pneumonias due to cytomegalovirus (CMV), phocyte antibody used (antithymocyte globulin in four centers Pneumocystis carinii, and Legionella pneumophila [2 -8] . Less and OKT3 in two centers). Prophylaxis for CMV, P. carinii, frequent studies have described radiographic manifestations and pneumococcal infections varied. Prophylaxis for CMV in- [9, 10] , risk factors [11] , and diagnostic methods [12] . fection with intravenous ganciclovir was administered only at However, we are not aware of any recent study that has one center, and it was indicated only for three patients who analyzed pneumonias overall as a clinical syndrome characterreceived OKT3. Prophylaxis for P. carinii infection was iniistic of HT. Therefore, we carried out a multiinstitutional study tially given in three centers, and the remainder administered to determine the clinical, radiographic, and prognostic characthis prophylaxis since 1993. Pneumococcal vaccination was teristics, the incidence, and the etiology of pneumonias in heart performed in four centers. transplant recipients.
All patients for whom pneumonia was diagnosed in the first year after transplantation were included in the study. We colPatients and Methods lected data following a previously designed protocol. The diagnosis of pneumonia was confirmed only when the clinical, We reviewed the clinical records of 307 consecutive heart radiographic, and microbiological criteria described below transplant recipients, of whom six (1.9%) required a second were met. transplant within the first postoperative year. The transplants Clinical and radiographic criteria. These criteria were as took place between 1 January 1992 and 31 December 1993 in follows: fever (temperature, ú38ЊC), cough, dyspnea, first six Spanish hospitals. The selection criteria for heart transplant phases of purulent expectoration, and/or changes in the previcandidates in the six centers involved in the study were the ous characteristics of respiratory secretions and chest roentpresence of an irreversible terminal heart disease without any genogram revealing a new or progressive alveolar or interstitial other therapeutic alternative and the absence of any major coninfiltrate or cavitation that could not be explained by any other noninfectious cause. Microbiological criteria. These criteria were as follows: isolation or detection of any microorganism (except CMV) in in the cases of polymicrobial pneumonia. The microorganism associated with the highest mortality rate was considered the most virulent.
Results
Bronchoscopy (95% sensitivity) was the diagnostic procedure most commonly used for obtaining respiratory samples. Incidence. Sixty-one heart transplant recipients had 65 episodes of pneumonia throughout the study period. The incidence There was a history of antimicrobial treatment in the 14 days before the sample was obtained in 12 episodes (18% 11.4) were the only independent factors with prognostic influence. After the episode of pneumonia, four patients died of The four cases with cavitated nodules were aspergillus pneumonia. Thoracic CT was carried out in 24 of the episodes of other causes, and the survival rate following the first year after HT was 61% (37 patients). pneumonia, and it improved the information obtained by simple roentgenography in eight cases (33%). It increased the number of visible nodules in 4 cases, demonstrated the existence of a Discussion single pulmonary nodule in 1, showed the presence of pulmonary cavitation in 1, and served for guiding the transparietal Pneumonia continues to be one of the most frequent infectious complications in heart transplant patients. In this study, puncture in 1.
Clinical manifestations. The main clinical characteristics the incidence was 21.1 episodes per 100 HTs in the first year. In another recent study involving 814 patients [13] , the inciand outcome are compared by etiologies in lower than previously reported: 24% -35% in the 1980s [9, 11] CMV is the most common copathogen, occurring in 80% of our cases and in 57% -70% of cases in other studies [9, 11] . and 50% -62% in the precyclosporine era [14, 15] . The first 3 months after HT is the period of highest risk; 75% of our cases P. carinii and Aspergillus species are less common copathogens. This association has been related to the immunosuppresoccurred in this period.
The etiology of pneumonia in heart transplant recipients is sive effect of CMV on the host, facilitating superinfection with other opportunists [16] . diverse. In this series, 82 microorganisms corresponding to 21 different genus and species were identified: 60% were opportu-CMV is the microorganism that most frequently causes pneumonia after HT; it accounted for 24% of the isolates in nistic microorganisms, 25% were nosocomial pathogens, and 15% were community-acquired bacteria and mycobacteria. Opthis study and 23% -32% of the isolates in other studies [9, 11] . The incidence of CMV pneumonia has decreased from 16 portunistic microorganisms also predominated in previous studies, constituting 50% -86% of the isolates [9, 11] . Pneumonias cases per 100 HTs in a study carried out between 1977 and 1988 [2] to 6.5 cases per 100 HTs in our study and to after HT are frequently polymicrobial, as were 23% of our cases and 24% -58% of cases in other studies [9, 11] , and 4.4 -7.7 cases per 100 HTs in other recent studies [3, 17, 18] . Early diagnosis and treatment of CMV infection have allowed monia was not associated with a higher frequency of previous viremia but was associated with a higher frequency of viremia for this decrease. The importance of viremia as a risk factor for developing CMV pneumonia is controversial. In bone marrow during the course of pneumonia than were pneumonias caused by other agents. transplant patients, it has a low sensitivity as a predictor for the development of pneumonia [19] . On the contrary, viremia
Aspergillus species were the second most common cause of has been identified as a predisposing factor for CMV pneumopneumonia in our study (16% of the isolates); the incidence of nia in liver transplant recipients [20] . In our study, CMV pneuaspergillus pneumonia was 4.2 cases per 100 HTs, similar to that described in recent series (from 1 to 4.5 cases per 100 HTs) [11, 13, 21] and lower than the 24% and 11% in the preand postcyclosporine eras, respectively [22] . The changes in absence of one specific prophylaxis. Prophylactic co-trimoxaNo 5/38 (13) zole is so effective that it reduces the incidence of P. carinii Mechanical ventilation pneumonia to nearly zero [7] . Other opportunistic microorganisms are far less common. The incidence of nocardia pneumonia went from 13% to 2% -treatment 3% in other studies [9, 11, 22] our study, and to 0.2% in a recent report [13] . In the case / 9c52$$au06 07-10-98 15:49:06 cida UC: CID R. equi is rarely a cause of pneumonia after HT, with only one CMV and P. carinii pneumonias than in other pneumonias (16% vs. 67%, respectively; P õ .05). Dyspnea was not characteristic previously described case [27] and our case. The incidence of pulmonary tuberculosis in heart transplant recipients in Spain, of M. tuberculosis, Nocardia species, and R. equi pneumonias (0 vs. 58% of other pneumonias; P õ .05). Nosocomial pneumonia 1% in this study and 1.35 cases per 100 HTs in a study by Muñoz et al. [28] , is 20 to 25 times higher than that estimated had the most acute presentation (median, 0; range, 1-3 days; P õ .05), and M. tuberculosis, Nocardia species, and R. equi for the general population [29] and higher than the rate of 0.1% reported in the United States and Canada [13] . Nontuberculous pneumonias had the most subacute presentation (median, 7 days; range, 6-50 days; P Å NS). mycobacteria are an exceptional cause of pneumonia after HT [30] and were not found in this study.
Some radiographic images are characteristic of determined etiologies of pneumonias after HT [9] . In this study, alveolar Nosocomial bacteria, in conjunction, are the leading cause of pneumonia after HT (29% of our cases); in our study, the infiltrates predominated in nosocomial pneumonias (95%), interstitial infiltrates and bilateral affliction in P. carinii pneumoincidence was 6.9 episodes per 100 HTs. Gram-negative bacilli predominated (57%), especially nonfermenting bacteria. The nia (82%), and cavitation in aspergillus pneumonia (38%; 33% in another series [10] ). CT is more sensitive than simple roentincidence of L. pneumophila pneumonia after HT varies: 0.3 case per 100 HTs in our study, 2% in a national surveillance genography for the diagnosis of acute pulmonary complications in immunodepressed patients [44] . It improved the information study carried out in the United States [31], and 7.8% in a nosocomial outbreak [32] . Some investigators recommend testobtained by simple roentgenography in 33% of the cases in our study. ing for L. pneumophila by surveillance cultures of the water supplies of centers with transplant programs [33] .
However, the diagnostic utility of clinical and radiographic manifestations in pneumonias after HT is limited. Only 50% Haemophilus influenzae and S. pneumoniae were the most common community-acquired bacteria in this series. The inciof the empirical treatments indicated in this study were appropriate. For this reason, quick diagnostic procedures that guide dence of pneumococcal pneumonia among heart transplant recipients (1 case per 100 HTs in this study and 2% -3.1% in the antimicrobial treatment are necessary. BAL is the main diagnostic procedure; the sensitivity of BAL was 89% in our other studies [11, 34] ), is higher than that among the general population (0.1% -0.2% [35] ). The Centers for Disease Control study and 67% in another study [12] . Other bronchoscopic procedures are less sensitive. Examination of sputum should and Prevention [36] recommend the pneumococcal vaccine for heart transplant recipients, although its effectiveness has not form part of the initial diagnostic study of pneumonia after HT, taking into account its limited sensitivity (47% in this been demonstrated. In our study, the frequency of pneumococcal pneumonia in vaccinated and unvaccinated patients was study) and specificity. In P. carinii pneumonia after HT, the value of sputum examination is low, 17% in this series and similar (3% vs. 9%, respectively; P Å NS). However, the validity of these data is limited because the study was not controlled.
20% in another study [5] , but higher than the rate of 3% referred to for other non-HIV-infected immunosuppressed patients [45] . Influenza virus type A [37] , parainfluenza virus [38] , parvovirus B19 [39] , respiratory syncytial virus [40] , herpes simplex virus Blood cultures are obligatory in the initial evaluation. In this study, 13% of the community-acquired pneumonias and 29% [9] , Mucor species [41] , and T. gondii [42] are unusual causes of pneumonia in heart transplant patients; these agents were of the nosocomial pneumonias were bacteremic. Pneumonia is one of the leading causes of death after HT. not identified in our study.
The timetable of infection in the organ transplant recipient, In this study, there were 6.5 deaths due to pneumonia per 100 heart transplant recipients, and 3.3%, 6%, and 7.6% of patients described by Rubin et al. [43] for renal transplant recipients, has been useful for diagnosis. In this study, we described the timetable died in other recent series [9, 11, 13] . The overall mortality among heart transplant recipients with pneumonia is from 23% for pneumonias after HT. In the first month, at a median of 20 days, nosocomial pneumonias appeared. In the second month, at to 25% [9, 11, 13] (31% in our study); this rate varies widely depending on the etiology. Aspergillus pneumonia has the a median of 35.5 and 36 days, respectively, CMV and aspergillus pneumonias appeared. At the end of the third month, at a median worst prognosis. The mortality rate associated with this pneumonia was 50% in a review involving 64 patients [46] and of 83.5 and 89 days, respectively, community-acquired and P. carinii pneumonias appeared. Finally, in the fourth month, at 62% in our series, where it was identified along with bilateral pulmonary infiltrates as an independent factor of poor prognoa median of 104.5 days, M. tuberculosis, Nocardia species, and R. equi pneumonias appeared. Aspergillus, CMV, and P. carinii sis. The mortality rate associated with P. carinii pneumonia in this study was 45%, much higher than the 9% in 33 cases from pneumonias appeared later at 1.8, 2.6, and 3.9 months, respectively, in another series [9] .
four series [5, 6, 9, 25] . This poor prognosis could be related to diagnostic delay since the response to co-trimoxazole treatMost of the clinical manifestations of pneumonias after HT are nonspecific but, in this study, some were characteristics of a ment is good, except when given to a patient receiving ventilatory support. Fortunately, the mortality rate associated with definite etiology: hemoptysis occurred more frequently in aspergillus pneumonias than in other pneumonias (54% vs. 6%, respec-CMV pneumonia has decreased from 56% [2] to 13% -20% [3, 18] ; it was 13% in this study. tively; P õ .05). Purulent expectoration was less common in CID 1998;27 (August) reduces mortality [47] . 
